Congressman blasts FDA for lax oversight of J&J’s P.R. plants
May 24, 2011
The head of the U.S House of Representatives Oversight Committee, Rep. Darrell Issa (R-Calif.), recently blasted the U.S. Food & Drug Administration for failing to properly monitor Johnson & Johnson’s McNeil unit in Las Piedras, which last year got into trouble for production flaws that led to massive recalls.
chat_bubble0 Comment
visibility9232 Views
Pharma sector growth pinned at 2.5% in ’11
December 27, 2010
esearch firm Business Monitor International on Monday predicted that Puerto Rico's pharmaceutical industry will show a slight growth of 2.5 percent next year, despite the looming threat of the effects of Law 154, which starting in January levies a 4 percent excise tax on foreign corporations doing business on the island.
chat_bubble0 Comment
visibility2747 Views
A Dow Jones/Factiva content provider since 2014
Subscribe to our Dollars & Sense podcast!
